BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1373310)

  • 1. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
    Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
    Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
    Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
    Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
    Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y
    Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
    Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
    Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of genetic alterations related to the development and progression of breast carcinoma.
    Nagayama K; Watatani M
    Jpn J Cancer Res; 1993 Nov; 84(11):1159-64. PubMed ID: 7903963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
    Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW
    Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17.
    Meling GI; Lothe RA; Børresen AL; Graue C; Hauge S; Clausen OP; Rognum TO
    Br J Cancer; 1993 Jan; 67(1):88-92. PubMed ID: 8094008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
    Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Amplification of the erbb-2 (Her-2/NEU), erbb-1 (HER-1) and c-myc oncogenes is often combined with the deletion of the short arm of chromosome 17 in human carcinoma].
    Imianitov EN; Chernitsa OI; Nikiforova IF; Serova OM; Sokolov SI; Laur OIu; Togo AV; Kniazev PG
    Mol Biol (Mosk); 1993; 27(4):888-94. PubMed ID: 8103188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
    Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
    J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
    Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H
    Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
    Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
    Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
    Mulligan LM; Gardner E; Smith BA; Mathew CG; Ponder BA
    Genes Chromosomes Cancer; 1993 Mar; 6(3):166-77. PubMed ID: 7682102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity and K-ras gene mutations in gastric cancer.
    Ranzani GN; Renault B; Pellegata NS; Fattorini P; Magni E; Bacci F; Amadori D
    Hum Genet; 1993 Oct; 92(3):244-9. PubMed ID: 8406432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
    Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth AN; Walker SJ; Sutton R; Meltzer SJ; Field JK
    Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
    Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
    Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer.
    Knyazev PG; Imyanitov EN; Chernitsa OI; Nikiforova IF
    Int J Cancer; 1993 Jan; 53(1):11-6. PubMed ID: 8416194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma.
    Thorlacius S; Jonasdottir O; Eyfjord JE
    Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.